Parnassus Endeavor Fund Holdings Activity

Parnassus Endeavor Fund Portfolio 13F

Parnassus Endeavor Fund has disclosed a total of 32 changes to the portfolio in the latest (2025 Q1) SEC report(s): increased the number of shares of 12, bought 2 totally new, decreased the number of shares of 16 and completely sold out 2 position(s).

What stocks is Parnassus Endeavor Fund buying now?

In the recent quarter Parnassus Endeavor Fund has bought 14 securities out of which top 5 purchases (by % change to portfolio) are (JPM) JPMORGAN CHASE & CO (new buy), (AMD) ADVANCED MICRO DEVICES (new buy), (NVO) NOVO-NORDISK A/S-SPONS ADR (added shares +55.98%), (FDX) FEDEX CORP (added shares +22.63%) and (CI) CIGNA CORP (added shares +20.39%).

What does Parnassus Endeavor Fund invest in?

Parnassus Endeavor Fund's top 5 holdings (by % of portfolio) are (SPGI) S&P GLOBAL INC (3.86%), (DE) DEERE & CO (3.65%), (SYY) SYSCO CORP (3.42%), (BAC) BANK OF AMERICA CORP (3.37%) and (VZ) VERIZON COMMUNICATIONS INC (3.34%).

In the latest report(s) the following change has been made to the top investments: (VZ) VERIZON COMMUNICATIONS INC (reduced shares -6.68%).

2025 Q1 (2 results)
AMD
buy
+479,833
+1.10%
$102.74
52.80% $156.99
1.10%
JPM
buy
+373,822
+2.05%
$245.30
18.74% $291.27
2.05%
2024 Q4 (6 results)
NVO
buy
+593,722
+1.06%
$86.02
25.24% $64.31
1.06%
V
buy
+250,085
+1.64%
$316.04
10.44% $349.05
1.64%
AZN
buy
+1,178,323
+1.60%
$65.52
4.99% $68.79
1.60%
BEPC
buy
+2,667,638
+1.53%
$27.66
31.42% $36.35
1.53%
ABNB
buy
+538,274
+1.77%
$131.41
6.03% $139.34
1.77%
AMAT
buy
+371,973
+1.26%
$162.63
17.10% $190.44
1.26%
2024 Q3 (2 results)
AMZN
buy
+503,495
+1.85%
$186.33
21.36% $226.13
1.85%
UNH
buy
+188,370
+2.18%
$584.68
51.66% $282.65
2.18%
2024 Q2 (2 results)
AGPXX
buy
+14,682,746
+0.30%
$1.00
-
0.30%
AVGO
buy
+335,780
+1.10%
$160.55
76.48% $283.34
1.10%
2024 Q1 (6 results)
buy
+407,500
+0.01%
$0.96
-
0.00%
CHTR
buy
+256,096
+1.42%
$290.63
31.47% $382.08
1.42%
NICE
buy
+163,392
+1.17%
$260.62
41.14% $153.41
1.17%
PFE
buy
+2,166,370
+1.69%
$27.75
11.82% $24.47
1.69%
buy
+100,000
+0.00%
$0.95
-
0.00%
buy
+250,000
+0.00%
$0.96
-
0.00%
2023 Q4 (4 results)
CBRE
buy
+493,864
+0.94%
$93.09
49.82% $139.47
0.94%
buy
+250,000
+0.00%
$0.97
-
0.00%
NTR
buy
+1,564,307
+1.79%
$56.33
6.53% $60.01
1.79%
TSM
buy
+476,163
+1.01%
$104.00
131.15% $240.40
1.01%
2023 Q3 (5 results)
EL
buy
+337,676
+1.41%
$144.55
39.67% $87.21
0.00%
DIS
buy
+639,588
+1.52%
$81.05
49.81% $121.42
1.52%
BIO
buy
+220,791
+1.74%
$358.45
31.26% $246.40
1.74%
BEPC
buy
+2,294,989
+1.21%
$23.94
51.84% $36.35
1.21%
CI
buy
+161,803
+1.02%
$286.07
3.37% $295.71
1.02%
2023 Q2 (3 results)
ADBE
buy
+79,024
+1.29%
$488.99
25.19% $365.79
1.29%
FIS
buy
+1,491,864
+1.75%
$54.70
46.86% $80.33
1.75%
INTC
buy
+2,779,094
+1.99%
$33.44
30.92% $23.10
1.99%
2023 Q1 (6 results)
BAX
buy
+1,773,720
+1.82%
$40.56
31.53% $27.77
1.82%
buy
+500,000
+0.01%
$0.96
-
0.01%
CME
buy
+136,603
+0.70%
$191.52
43.43% $274.70
0.70%
buy
+250,000
+0.01%
$0.94
-
0.01%
buy
+100,000
+0.00%
$0.95
-
0.00%
buy
+250,000
+0.01%
$0.96
-
0.01%
2022 Q4 (6 results)
ALGN
buy
+327,051
+1.68%
$210.90
9.54% $190.77
1.68%
AMAT
buy
+222,448
+0.47%
$97.38
95.56% $190.44
0.47%
IFF
buy
+407,975
+1.10%
$104.84
27.51% $76.00
1.10%
TGT
buy
+630,045
+2.04%
$149.04
30.58% $103.46
2.04%
buy
+177,500
+0.01%
$0.97
-
0.01%
C
buy
+1,044,274
+1.48%
$45.23
106.61% $93.45
1.48%
2022 Q3 (3 results)
BLL
buy
+1,119,340
+2.02%
$48.32
43.81% $69.49
2.02%
ORCL
buy
+1,358,062
+2.00%
$61.07
301.92% $245.45
2.00%
SBNY
buy
+485,426
+1.77%
$151.00
99.60% $0.60
1.77%
2022 Q2 (3 results)
DOX
buy
+844,191
+1.56%
$83.31
7.33% $89.42
1.56%
DE
buy
+287,730
+1.91%
$299.47
66.90% $499.82
1.91%
ROST
buy
+774,665
+1.21%
$70.23
85.02% $129.94
1.21%
48 of 57

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.